Literature DB >> 10843360

Determinants of intestinal metaplasia within the columnar-lined esophagus.

S Oberg1, J H Peters, T R DeMeester, R V Lord, J Johansson, S R DeMeester, J A Hagen.   

Abstract

HYPOTHESIS: The clinical and physiological features of patients with short segments of columnar-lined esophagus (CLE) with and without intestinal metaplasia (IM) are distinct.
DESIGN: Retrospective case series.
SETTING: University tertiary referral center. PATIENTS: Sixty-five consecutive patients with a 2-cm or shorter length of endoscopically visible CLE.
INTERVENTIONS: The type of CLE and the presence of Helicobacter pylori were determined by histopathologic examination of esophageal and gastric antrum biopsy specimens. All patients underwent esophageal manometry and simultaneous 24-hour pH and bilirubin monitoring. MAIN OUTCOME MEASURES: Clinical and physiological data were compared in patients with and without IM.
RESULTS: Thirty-six patients had IM and 29 had cardiac-type mucosa without IM in biopsy specimens from the CLE. There was no significant difference in age or sex distribution, but the duration of symptoms was significantly longer in patients with IM (10 vs 5 years; P = .03). Abnormal esophageal acid exposure was found in 30 (83%) of 36 patients with IM and 23 (79%) of 29 patients without IM. The prevalence of abnormal bilirubin exposure was significantly higher in patients with IM (75% [27/36]) than in those without IM (41% [12/29]; P = .01). There was no significant difference in the prevalence of H pylori infection between the 2 groups (8% vs 10%; P >.99).
CONCLUSIONS: Patients with short segments of CLE and IM have similar esophageal acid exposure but significantly higher frequency of abnormal bilirubin exposure and longer median duration of reflux symptoms than patients without IM. Therefore, CLE, regardless of histological type, is a manifestation of gastroesophageal reflux disease. The presence of duodenoesophageal reflux and the duration of reflux seem to be important in the pathogenesis of IM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843360     DOI: 10.1001/archsurg.135.6.651

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  10 in total

Review 1.  The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia.

Authors:  P Malfertheiner; U Peitz
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?

Authors:  Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

3.  Metaplastic columnar mucosa in the cervical esophagus after esophagectomy.

Authors:  Stefan Oberg; Jan Johansson; Jörgen Wenner; Bruno Walther
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

4.  Barrett's esophagus without esophageal stricture does not increase the rate of failure of Nissen fundoplication.

Authors:  Pascual Parrilla; Luisa F Martínez de Haro; Angeles Ortiz; Vicente Munitiz; Andres Serrano; Gloria Torres
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

5.  Endoscopic surveillance of columnar-lined esophagus: frequency of intestinal metaplasia detection and impact of antireflux surgery.

Authors:  S Oberg; J Johansson; J Wenner; F Johnsson; T Zilling; C S von Holstein; J Nilsson; B Walther
Journal:  Ann Surg       Date:  2001-11       Impact factor: 12.969

Review 6.  From Heartburn to Barrett's Esophagus, and Beyond.

Authors:  Francisco Schlottmann; Marco G Patti; Nicholas J Shaheen
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

7.  Intraluminal pH and goblet cell density in Barrett's esophagus.

Authors:  Dimitrios Theodorou; Shahin Ayazi; Steven R DeMeester; Joerg Zehetner; Christian G Peyre; Kimberly S Grant; Florian Augustin; Daniel S Oh; John C Lipham; Parakrama T Chandrasoma; Jeffrey A Hagen; Tom R DeMeester
Journal:  J Gastrointest Surg       Date:  2011-11-18       Impact factor: 3.452

8.  The molecular pathogenesis of Barrett's esophagus: common signaling pathways in embryogenesis metaplasia and neoplasia.

Authors:  Jeffrey H Peters; N Avisar
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

9.  Interleukin-6, desmosome and tight junction protein expression levels in reflux esophagitis-affected mucosa.

Authors:  Fei-Yue Li; Yan Li
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

10.  Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy.

Authors:  Herbert C Wolfsen; Lois L Hemminger; Kenneth R DeVault
Journal:  BMC Gastroenterol       Date:  2004-08-25       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.